January 18, 2018 10:00 AM EST

Carmot closes $15M round to advance diabetes drug; Argos board clears reverse stock split, moves to small cap market

Amber Tong

→ In a last-ditch effort to stay on Nasdaq, Argos Therapeutics $ARGS is going for a one-for-twenty reverse stock split, effective after the close …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Carmot closes $15M round to advance diabetes drug; Argos board clears reverse stock split, moves to small cap market

Amber Tong

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Key GOP senator is ‘struggling’ with Kennedy nomination over vaccine answers

Takeda scraps programs as it raises full-year guidance

Cargo Therapeutics cuts lead CAR-T program, 50% of staff

Rentschler exits cell and gene business due to low demand, will prioritize biologics

FDA approves Axsome's acute migraine treatment after 2022 rejection

Why the premier recruitment agency in the world is giving up recruiting, and sponsors should, too

Car­mot clos­es $15M round to ad­vance di­a­betes drug; Ar­gos board clears re­verse stock split, moves to small cap mar­ket

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Carmot closes $15M round to advance diabetes drug; Argos board clears reverse stock split, moves to small cap market